Standard BioTools Inc. (LAB)

NASDAQ: LAB · IEX Real-Time Price · USD
2.760
+0.070 (2.60%)
Mar 28, 2024, 2:14 PM EDT - Market open

Company Description

Standard BioTools Inc., together with its subsidiaries, provides instruments, consumables, reagents, and software services for researchers and clinical laboratories in the Americas, Europe, the Middle East, Africa, and the Asia pacific.

It operates through two segments: Proteomics and Genomics. The company offers analytical systems, such as CyTOF XT System, a CyTOF XT mass cytometry system performs automated high-parameter single-cell analysis using antibodies conjugated to metal isotopes; and Hyperion XTi imaging system, a spatial biology instrument.

It also provides genomics, such as X9 Real-Time PCR System, a real-time PCR analytical instrument including pre-processing steps for microfluidics-based workflows using (integrated fluidic circuit) IFCs; and IFC Controllers, a controller which is designed to work with IFC formats.

In addition, the company offers analytical instruments comprising Biomark HD system, a real-time PCR analytical instrument for microfluidics-based workflows using prepared IFCs.

It sells its products to academic research institutions; translational research and medicine centers; cancer centers; clinical research laboratories; biopharmaceutical, biotechnology, and plant and animal research companies; and contract research organizations.

It has license agreements with California Institute of Technology, Harvard University, and Caliper Life Sciences, Inc. The company was formerly known as Fluidigm Corporation and changed its name to Standard BioTools Inc. in April 2022.

Fluidigm Corporation was incorporated in 1999 and is headquartered in South San Francisco, California.

Standard BioTools Inc.
Standard BioTools logo
Country United States
Founded 1999
IPO Date Feb 10, 2011
Industry Diagnostics & Research
Sector Healthcare
Employees 534
CEO Dr. Michael Egholm Ph.D.

Contact Details

Address:
2 Tower Place, Suite 2000
South San Francisco, California 94080
United States
Phone (650) 266-6000
Website fluidigm.com

Stock Details

Ticker Symbol LAB
Exchange NASDAQ
Fiscal Year January - December
Reporting Currency USD
CIK Code 0001162194
CUSIP Number 34385P108
ISIN Number US34385P1084
Employer ID 77-0513190
SIC Code 3826

Key Executives

Name Position
Dr. Michael Egholm Ph.D. President, Chief Executive Officer and Director
Hanjoon Kim Chief Operating Officer
Jeffrey G. Black Chief Financial Officer
Dr. Shane Bowen Ph.D. Chief Technology Officer
Adam Taich Chief Strategy Officer

Latest SEC Filings

Date Type Title
Mar 20, 2024 SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals
Mar 20, 2024 SC 13D/A [Amend] General statement of acquisition of beneficial ownership
Mar 19, 2024 144 Filing
Mar 18, 2024 144 Filing
Mar 18, 2024 8-K Current Report
Mar 14, 2024 144 Filing
Mar 1, 2024 10-K Annual Report
Feb 28, 2024 8-K Current Report
Feb 26, 2024 SC 13G Statement of acquisition of beneficial ownership by individuals
Feb 14, 2024 SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals